EUCTR2018-002640-82-DK进行中（未招募）1 期
A randomized, controlled, multicentre trial regarding the safety and feasibility of treatment with empagliflozin compared with NPH insulin treatment in patients with newly onset diabetes following initiation of glucocorticoid treatment. - EANITIATE
ordsjællands Hospital0 个研究点目标入组 74 人开始时间: 2018年9月13日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 74
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Written signed informed consent prior to any study specific procedures
- •2.Recent (within a week) diagnosis of GIDM (defined as non-fasting plasma glucose measured > 11.1 mmol/l at two different occasions, OR at one occasion above 11.1 mmol/L with classical hyperglycaemia symptoms, OR a fasting plasma glucose of >7 mmol/L).
- •3.Hospitalized at the time of screening.
- •4.Patients >18 years at the time of consent.
- •5.eGFR = 60 ml/min/1.73 m2 (estimated by CKD-EPI formula) at visit 1
- •6.Female patients must use contraception. The following contraceptives are considered as safe contraception in drug trials: Intra-uterine-device or hormonal contraception (birth control pills, implant, transdermal patch, vaginal ring or depot injection). Sterile or non-fertile subjects are exempted from the requirement for contraception. In order to be considered sterile or non-fertile, one must generally be surgically sterilized (bilateral oophorectomy or hysterectomised at least six months prior to screening) or be postmenopausal, defined as non-menstrual period for at least 12 months before studying. For some individuals or special populations, there may be relationships that speak against the use of the above methods. Examples may be severely impaired hospitalized patients. Such an assessment is taken by the investigator and is his responsibility
- •7.Must be able to communicate with the study personnel.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 37
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 37
排除标准
- •Exclusion criteria
- •1.Known diabetes (treated or not treated) prior to initiation of glucocorticoid treatment.
- •2.Use of any blood glucose-lowering medication for the last 30 days prior to the trial for any reason, except up to 2 doses of insulin prior to screening
- •3.Hyperglycaemia with a glucose level >20mmol/L
- •4.Any former or ongoing pancreatic disorder.
- •5.Known or suspected hypersensitivity to trial product(s) or products with the same content/known cross-reactivity.
- •6.Females of childbearing potential who are pregnant, breast-feeding, intend to become pregnant or are not using adequate contraceptive methods.
- •7.The receipt of any investigational product 30 days prior to this trial
- •8.Known or suspected abuse of alcohol or drugs.
- •9.Suspected non-compliance with the protocol (as judged by the investigator).
- •10.Involvement in the planning/or conduct of the study
- •11.Previous randomisation in the study
- •12.Participation in another study with an investigational product during the last 30 days prior to enrolment
- •13. Age > 85 years.
研究者
相似试验
进行中（未招募）
不适用
A multi-center, randomized, controlled trial with programmed introduction of Sirolimus-based, Calcineurin inhibitor free immunosuppression in recipients of non-heart-beating donor kidney grafts. - PRINS studyEUCTR2007-002763-27-NLErasmus MC
已完成
4 期
A multi-center, randomized, controlled trial with programmed introduction of Sirolimus-based, Calcineurin inhibitor free immunosuppression in recipients of non-heart-beating donor kidney grafts.kidney transplant function10038430NL-OMON31753Erasmus MC, Universitair Medisch Centrum Rotterdam100
已完成
不适用
A multicenter,randomized,controlled clinical trial of early vitrectomy for diffuse diabetic macular edema.diffuse diabetic macular edemaJPRN-UMIN000008957Kagoshima University Graduate School of Medical and Dental Science162
已完成
不适用
A multicentre, randomized, controlled trial of Probiotic and Peanut Oral Immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with Oral Immunotherapy (OIT) alone and with placebo.Peanut AllergyInflammatory and Immune System - AllergiesFood AllergyACTRN12616000322437Murdoch Childrens Research Institute201
进行中（未招募）
不适用
A multi-centred, randomized, controlled trial comparing weight loss in endoscopically implanted duodenal-jejunal bypass liners vs intragastric balloons vs a sham procedureE66E11Type 2 diabetes mellitusObesityDRKS00011036niversität Leipzig33